Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

Presentation TCT 2025

Under Pressure

Presenter: David E. Kandzari

October 27, 2025

Presentation TCT 2025

Symplicity Spyral™ in the Real World: Results from the Cleveland Clinic

Presenter: Aravinda Nanjundappa

October 27, 2025

Presentation TCT 2025

University of Pennsylvania's Hypertension Program

Presenter: Raymond R. Townsend

October 27, 2025

Presentation TCT 2025

RDN in Global Guidelines

Presenter: Felix Mahfoud

October 27, 2025

Presentation TCT 2025

Patient Selection and Shared Decision Making

Presenter: Raymond R. Townsend

October 27, 2025

Presentation TCT 2025

NCD

Presenter: David E. Kandzari

October 27, 2025

Presentation TCT 2025

Symplicity Spyral™

Presenter: Eric A. Secemsky

October 27, 2025

Presentation TCT 2025

Global Hypertension Crisis

Presenter: Eric A. Secemsky

October 27, 2025

Presentation TCT 2025

Welcome

Presenter: David E. Kandzari

October 27, 2025

Presentation TCT 2025

Durable Safety and Efficacy of Renal Denervation using the Symplicity Spyral Catheter in Patients Taking Antihypertensive Drugs: Final, 3-Year Results from the SPYRAL HTN-ON MED Randomized Study

Presenter: David E. Kandzari

October 26, 2025

Presentation TCT 2023

TCT 267: Pooled, 12-month Blood Pressure Reductions Using the Symplicity Spyral Radiofrequency Renal Denervation Catheter

Presenter: Felix Mahfoud

October 25, 2023

Presentation TCT 2016

TCT 762: Renal Denervation Treatment With the Symplicity Spyral Multielectrode Catheter: Six-Month Safety and Blood Pressure Outcomes From the Global SYMPLICITY Registry

Presenter: Melvin D. Lobo, Adam Witkowski

October 31, 2016

Presentation TCT 2016

Device Overview and Ongoing Study Design: Medtronic GLOBAL SYMPLICITY SPYRAL HTN Trial Program

Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, David E. Kandzari

October 30, 2016

Presentation TCT 2014

Renal Artery Denervation With A New Simultaneous Multielectrode Catheter For Treatment Of Resistant Hypertension: 12-Month Update From The SYMPLICITY Spyral First-In-Man Study

Presenter: Robert Whitbourn

September 16, 2014

Presentation TCT 2014

24h Ambulatory Blood Pressure (ABPM) Change After Using The New Symplicity Spyral Renal Sympathetic Denervation Device In Patients With Resistant Hypertension ? First Results Fr___

Presenter: Alexander Plehn

September 16, 2014

Presentation TCT 2013

Device and Clinical Trial Update: Symplicity and Spyral (Medtronic)

Presenter: David Kandzari

October 27, 2013

Advertisement

Under Pressure

Symplicity Spyral™ in the Real World: Results from the Cleveland Clinic

University of Pennsylvania's Hypertension Program

RDN in Global Guidelines

Patient Selection and Shared Decision Making

NCD

Symplicity Spyral™

Global Hypertension Crisis

Welcome

Durable Safety and Efficacy of Renal Denervation using the Symplicity Spyral Catheter in Patients Taking Antihypertensive Drugs: Final, 3-Year Results from the SPYRAL HTN-ON MED Randomized Study

TCT 267: Pooled, 12-month Blood Pressure Reductions Using the Symplicity Spyral Radiofrequency Renal Denervation Catheter

TCT 762: Renal Denervation Treatment With the Symplicity Spyral Multielectrode Catheter: Six-Month Safety and Blood Pressure Outcomes From the Global SYMPLICITY Registry

Device Overview and Ongoing Study Design: Medtronic GLOBAL SYMPLICITY SPYRAL HTN Trial Program

Renal Artery Denervation With A New Simultaneous Multielectrode Catheter For Treatment Of Resistant Hypertension: 12-Month Update From The SYMPLICITY Spyral First-In-Man Study

24h Ambulatory Blood Pressure (ABPM) Change After Using The New Symplicity Spyral Renal Sympathetic Denervation Device In Patients With Resistant Hypertension ? First Results Fr___

Device and Clinical Trial Update: Symplicity and Spyral (Medtronic)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content